Skin Therapist Tegan Mac and I dove deep into all things eye care. I shared one of my favourite full coverage, brightening ...

Below, we’ve rounded up many of Amazon’s most highly-rated anti-aging skin care products. They include must-have effective ...

You don’t always have to shell out a pretty penny to get great results: Drugstore skin care products are proof of that.

The serum is basically a more concentrated version of a tinted moisturizer, offering an extra boost of hydration and coverage. The result? A flawless, velvety finish that makes your skin appear ...

Almost every scene of the powerful "La Cocina" takes place in or just outside the kitchen of a Times Square tourist trap bluntly dubbed The Grill. It's one of those places that does a bit of ...

Roche CEO: not good to limit competition in this space Roche says not itself, but others affected by Catalent deal Swiss drugmaker joins US peer Lilly in voicing opposition Eli Lilly and advocacy ...

Speaking to the press Wednesday, Roche’s chief executive Thomas Schinecker critiqued the proposed transaction, arguing that it could hamper the ability of smaller biopharma players to lock down ...

Swiss Pharmaceutical giant Roche Holding (OTCQX:RHHBY) (OTCQX:RHHBF) on Wednesday reaffirmed its full-year sales and earnings outlook after the company’s third-quarter sales results exceeded ...

Roche doesn’t think so. “I think we don’t see anything that should be slowing Vabysmo momentum down,” Teresa Graham, CEO of Roche Pharmaceuticals, said during a press conference Wednesday ...

Roche ROG-1.53%decrease; red down pointing triangle confirmed its profit outlook for the year after its eye drug Vabysmo, multiple-sclerosis treatment Ocrevus and hemophilia injection Hemlibra ...

FRANKFURT, Oct 23 (Reuters) - The CEO of Roche (ROG.S), opens new tab said he has been informed that more cases of mpox infection have occurred in Europe than previously reported and that the ...

Jefferies analyst Peter Welford noted that Roche’s pharma group came just slightly ahead of consensus expectations, driven by strong performance of its multiple sclerosis therapy Ocrevus and eye ...